The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment

Abstract

Chloride ions play a major role in osteoclast biology and bone homeostasis. In addition to its general cellular roles, chloride is involved in the specific bone resorption activity of osteoclasts. The chloride channel ClC-7 has been shown to be mandatory for bone resorption. It is necessary for the acidification of the resorption lacunae. In addition to ClC-7, other chloride channels and exchangers have been identified in osteoclasts. The bicarbonate-chloride exchanger at the plasma membrane of osteoclasts is important for regulating the cytoplasmic pH during bone resorption. The role of the additional chloride channels or putative chloride channels identified in osteoclasts, volume-regulated anion channel, Chlor.62 and CLIC1 has not been established. To date, ClC-7 is the only known chloride channel whose disruption or mutation leads to a bone disease: osteopetrosis, which is characterized by an increased bone mass. Inhibition of ClC-7 constitutes a new potential way to treat osteoporosis. The expression of ClC-7 is restricted to few tissues with very high expression in the osteoclasts in bone. Pharmacologically, inhibitors of acidification of the resorption lacunae have proved to be unique, as inhibition leads to a decrease in bone resorption without affecting bone formation, suggesting that the coupling principle has been challenged. Thus, ClC-7 inhibitors may prove to be potent for prevention and treatment of osteoporosis.